-Medknow 132 consolidation therapy. Consolidation therapy consisted of high-dose cytarabine (1.5 mg to 3 mg/m 2 ) [5] over 2-3 h 12 hourly on days 1, 3, and 5. During consolidation, protocol for treating febrile episodes and culture collections were same as per induction.
Introduction
Treatment of acute myeloid leukemia (AML) consists of induction therapy with anthracyclines and cytarabine followed by two to four cycles of consolidation therapy with high-dose cytarabine after achieving remission. [1] The induction and consolidation therapies are known to be complicated with infections during neutropenia. Till the late 1960s, Gram-negative infections were predominant infection during therapy of AML. Over the next two to three decades, the predominant infection during therapy changed from Gram-negative to -positive organisms. Recent bloodstream infection rates during induction have been 27.8% and during consolidation phase has been around 25%. The predominant organisms during induction were Gram-positive (80%); those during consolidation were Gram-negative (72%). [2] There have been very few Indian studies comparing infections during induction and consolidation. We have analyzed blood cultures of patients with AML during episodes of fever occurring during induction and consolidation therapy at our institute during the years 2014-2015 to compare the infective organisms during induction and consolidation.
Materials and Methods
This is a retrospective analysis carried out at our institute from June 2014 to July 1015. Patients with AML were treated at our institute with induction therapy of daunorubicin 60 mg/m 2 (days 1-3) and cytarabine (100-200 mg/m 2 ) continues infusion over 24 h (days 1-7). [1] When the patients developed fever defined as 101°F single-episode or 100.4°F continues for 1 h or more, blood cultures from central venous catheter and peripheral blood were collected along other investigation. Infective episodes were treated as per generally accepted guidelines. [3] Those in remission, [4] postconsolidation (defined as <5% blast without hypocellularity, no extramedullary disease) were started on This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
For reprints contact: reprints@medknow.com phases of treatment of AML therapy. We had 52 AML patients, who did not receive prophylactic antibiotics during therapy except antifungal in the form of fluconazole. The incidence of blood culture-positive infections during induction was 48%, which is higher compared with studies from the West where it is reported to be 29.6% [7] while it is lower compared to data reported from India of 65%. [6] During the last few years, there has been a shift from Gram-negative infections to Gram-positive infections during acute leukemia therapy probably related to increased use of intravascular catheters, fluoroquinolone prophylaxis. However, in our study, the incidence of culture positive infections during induction was 48%, of which 60% were caused by Gram-negative organisms, 36% by Gram-positive organisms, and 4% yeast [ Figure 1 ]. During consolidation, the culture positive infections were 25.5%, of which the Gram-negative infections constituted 50%, Gram-positive infections were 41.66%, and polymicrobial infection were reported in only 1 (8.33%) patient, both were gram-negative organisms [ Figure 1 ]. On analyzing the bloodstream infection, the incidence of blood culture-positive infection was almost double during induction compared to consolidation. Contrary to our assumption, the consolidation would have more of Gram-negative infections compared to induction in view of increased gastrointestinal toxicity of high-dose cytarabine. This could probably be explained by the active disease during induction compared to consolidation. Our result correlates with Indian studies showing predominant Gram-negative infection in cancer patients. [8] 
Conclusion
The incidence of blood culture-positive infections during therapy of AML at our center was higher. The predominant organism isolated was Gram-negative during both induction and consolidation. The incidence of blood culture-positive infections had decreased by 50% during consolidation. 
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